Target intelligence / Profile preview

Cancer susceptibility candidate 6 (non-protein coding) (CASC6)

Target: CASC6
Molecular classification: Other (long non-coding RNA, lncRNA)

Overview

Cancer susceptibility candidate 6 (CASC6) is a long non-coding RNA gene located on chromosome 6q15 and does not encode a protein. It is listed in genetic databases as an lncRNA, not as a classic therapeutic target such as a receptor, enzyme, or transporter. There is no current evidence that CASC6 is a validated therapeutic target or involved in specific biological pathways or diseases through direct, characterized mechanisms. This entry appears to reflect a gene locus rather than a protein, receptor, or actionable molecular target[2][3][4][5][6][9].

Other names: Cancer susceptibility 6RP3-433F14.3

Beyond the preview

Go deeper on Cancer susceptibility candidate 6 (non-protein coding) (CASC6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cancer susceptibility candidate 6 (non-protein coding) (CASC6).

Explore the full profile